The clinical trials of diaspirin cross-linked hemoglobin (DCLHb) in severe traumatic hemorrhagic shock: the tale of two continents

Intensive Care Med. 2003 Mar;29(3):347-9. doi: 10.1007/s00134-003-1637-y.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Aspirin / analogs & derivatives*
  • Aspirin / therapeutic use*
  • Blood Substitutes / therapeutic use*
  • Clinical Trials as Topic
  • European Union
  • Hemoglobins / therapeutic use*
  • Humans
  • Shock, Hemorrhagic / drug therapy*
  • Shock, Hemorrhagic / etiology
  • Wounds and Injuries / complications

Substances

  • Blood Substitutes
  • Hemoglobins
  • diaspirin-cross-linked hemoglobin
  • Aspirin